CNBC Business News Update - Market Midday: Stocks Lower, Insurance Industry Watches Hurricane Erin, Samsung Taking Market Share From Apple 8/18/25

Episode Date: August 18, 2025

From Wall Street to Main Street, the latest on the markets and what it means for your money. Updated regularly on weekdays, featuring CNBC expert analysis and sound from top business newsmakers. Anchored by CNBC's Jessica Ettinger.

I'm Jessica Ettinger, CNBC. Wall Street modestly lowered this afternoon to start the week of trading. The Dow down 21 points being led lower by shares of Boeing, which are down one and a half percent. The S&P 500 index is down six points. The NASDAQ is down 35 points. Invidia shares are in the green this afternoon. They're up a half percent. European leaders are arriving in Washington, D.C. for the Trump-Zolensky-Ukraine meetings. Some are worried that President Trump has turned to favor Russia's stance on the war it started after his meeting with Vladimir Putin last week. The insurance industry is on alert as Hurricane Aaron is forecast to create dangerous surf and winds and flooding along North Carolina's outer banks. It's not forecast to make U.S. landfall, however. Novo Nordisk shares were popping today after the FDA approved its weight loss drug, Wagovi, as a treatment for serious liver disease, affecting about 5% of.

of the U.S. population. Ozempic, the diabetes drug, will be available for people just to buy. That's another change. Novo is saying that they're going to start selling Ozmpic directly to consumers. This will expand its NovoCare platform that already carries weight loss shot with Govee.

Now remember, this is a diabetes drug, and Ozambic will be available for $4.99 a month for people paying out of pocket. Novo is also announcing that it's working with good RX to make that $49 cash price for Ozambic and will be available, and more than 70,000 pharmacies nationwide, so that's another expansion. And this is all just a part of Novo trying to fight back against the compounders who are selling those knockoff versions of Samagletide.

So anything that Novo can do, really, to make this drug more affordable to people who are willing to pay out of pocket could help them claw back some of that share that they've been losing. CNBC's Angelica Peoples. Bitcoin is pulled back to about 115,000 today as people sell out over macroeconomic worry. and comments by the Treasury Secretary that the U.S. Strategic Bitcoin Reserve President Trump established back in March will be confined just to Bitcoin forfeited to the federal government.

The government's not buying any. Samsung is taking market share from Apple in the U.S. as foldable phones gain momentum. Data shows that Samsung is taking market share from Apple in the United States. Smartphone market research firm canalesis shows that shipments from Samsung to the U.S. surged in the second quarter. The company's market share rising from 23% all the way to 31%

while Apple's market share declined from 56% to 49%. CNBC's Becky Quick. Universal says it's releasing the Breakfast Club movie into theaters to market's 40th anniversary. It'll be nationwide two nights, Sunday, September 7th and again on Wednesday, September 10th. Universal's a sister company to CNBC. Warner Brothers owned New Line's weapons took the top spot at the weekend box office for the second week in a row. Jessica Eddinger, CNBC. Introducing CNBC Plus, the new streaming platform from the number one source in business news. Watch live or on demand. Access any market, any time, anywhere. Start streaming. Go to CNBC.com slash plus now.